Urinalysis Market Report Scope & Overview:

The Urinalysis Market Size was valued at USD 4.06 billion in 2022 and is expected to reach USD 6.98 billion by 2030, and grow at a CAGR of 7% over the forecast period 2023-2030.

Urinalysis is a urine sample analysis test that aids in the detection of a variety of conditions like diabetes, kidney disease, and urinary tract infection. Its main goal is to keep track of people's health. Urinalysis is performed as part of a general medical check-up, as part of pre-surgery preparation, as part of a pregnancy check-up, or as part of a hospital admission for various diseases. It also aids in determining the source of symptoms like back pain, abdominal pain, and uncomfortable urination.

Urinalysis Market Revenue Analysis

Get more information on Urinalysis Market - Request Sample Report

The increasing frequency of kidney illnesses, the adoption of PPACA, and the growing geriatric population are all factors driving the global urinalysis market forward. Meanwhile, the US government's imposition of an excise tax and strong regulations procedures are limiting the market's expansion. Integrated systems and urinalysis via cellphones, as well as technical advancements, give business potential.



  • The elderly population is growing.

  • Urinary parcel disease is turning out to be more normal.

  • Constant renal illness is turning out to be more normal over the world.


  • Reimbursement situation that is not favourable


  • Urinalysis growth possibilities in developing economies

  • Development of technology in urinalysis


  • The supervisory environment could make growth even more difficult.


The COVID-19 epidemic had a negative impact on most businesses' overall sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests conducted and reagent sales. Nevertheless, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. People hospitalized with COVID-19 are at a high risk of AKI, which can lead to serious illness, dialysis, and even death, as per the National Kidney Foundation.

The reclaimed COVID-19 people with AKI or ARF (acute renal failure) should see a kidney doctor on a frequent basis because their risk of chronic kidney disease is more than others. Patients with COVID-19 who did not develop AKI but had blood or protein in their urine should be closely watched because they have a greater risk of getting the chronic and end-stage renal disease. With the COVID-19 pandemic, there is an increasing desire for the development of more accurate and simple testing methods, as well as the growth of testing structures, in addition to vaccinations and therapeutic medications.

As governments and healthcare providers confront extraordinary problems, COVID-19 has an impact on the regulatory environment and practises. Government regulators used a variety of techniques to expedite the approval of diagnostic products. Organizations have gone with vital choices to execute COVID-19 fast tests, keep up with income, and moderate COVID-19's effect on their working abilities.


The worldwide urinalysis market is separated into the product, test type, application, end client. The dipstick, reagent, urine analyzer, and POC product segments are further divided. Biochemical, sediment, and microscopic tests are addressed in the study. The paper covers diagnosis, diabetes, urinary tract infections, kidney disease, and pregnancy. The report's end consumers include homes, hospitals, and research organizations.


By Product Type

  • Consumables

    • Pregnancy & Fertility Kits

    • Reagents

    • Dipsticks

    • Disposables

  • Instruments

    • Automated Urine Analyzers

    • Point-of-Care Urine Analyzers

    • Semi-automated Urine Analyzers

By Test

  • Pregnancy & Fertility Tests

  • Sediment Urinalysis

  • Biochemical Urinalysis

    • POC Tests

    • Laboratory Tests

By Application

  • Disease Screening

    • Urinary Tract Infections

    • Liver Diseases

    • Kidney Diseases

    • Diabetes

    • Other

  • Pregnancy and Fertility

By End User

  • Diagnostic Laboratories

  • Home Care Settings

  • Research Laboratories

  • Hospitals and Clinics

Urinalysis Market Segmentation Analysis

Need any customization research on Urinalysis Market - Enquiry Now


North America, Europe, Asia Pacific, and the Rest of the World make up the urinalysis market. North America held the highest proportion of the worldwide urinalysis market in 2021. The growing elderly population, implementation of favourable government programmes, increased healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments all contribute to the growth of the North American urinalysis market.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America


Some of the major key players are as follows are Roche DiagnosticsSiemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players.

Sysmex Corporation-Company Financial Analysis

Company Landscape Analysis

Urinalysis Market Report Scope:
Report Attributes Details
Market Size in 2022  US$ 4.06 Billion
Market Size by 2030  US$ 6.98 Billion
CAGR  CAGR of 7% From 2023 to 2030
Base Year  2022
Forecast Period  2023-2030
Historical Data  2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product Type (Consumables (Pregnancy & Fertility Kits, Reagents, Dipsticks, Disposables)
• By Instruments (Automated Urine Analyzers, Point-of-Care Urine Analyzers, Semi-automated Urine Analyzers)
• By Test (Pregnancy & Fertility Tests, Sediment Urinalysis, Biochemical Urinalysis)
• By Application (Disease Screening, Pregnancy and Fertility)
• By End User (Diagnostic Laboratories, Home Care Settings, Research Laboratories, Hospitals and Clinics)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players.
DRIVERS • The elderly population is growing.
• Urinary parcel disease is turning out to be more normal.
• Constant renal illness is turning out to be more normal over the world.
RESTRAINTS • Reimbursement situation that is not favourable

Frequently Asked Questions

Ans:- The Urinalysis is growing at a CAGR of 7% over the forecast period 2023-2030.

Ans: - The Urinalysis Market Size was valued at US$ 4.06 Bn in 2022.

The urinalysis Market is divided into four segments and they are By Product Type, By Test Type, By Application Type, and, By End User Type

North America held the highest proportion of the urinalysis market.

Manufacturer and service provider, research institutes, universities, and private libraries, suppliers, and distributors.

Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8 Urinalysis Market Segmentation, by Product Type

8.1 Consumables

8.1.1 Pregnancy & Fertility Kits

8.1.2 Reagents

8.1.3 Dipsticks

8.1.4 Disposables

8.2 Instruments

8.2.1 Automated Urine Analyzers

8.2.3 Point-of-Care Urine Analyzers

8.2.4 Semi-automated Urine Analyzers

9. Urinalysis Market Segmentation, By Test Type

9.1 Pregnancy & Fertility Tests

9.2 Sediment Urinalysis

9.3 Biochemical Urinalysis

9.3.1 POC Tests

9.3.2 Laboratory Tests

10. Urinalysis Market Segmentation, By Application Type

10.1 Disease Screening

10.1.1 Urinary Tract Infections

10.1.2 Liver Diseases

10.1.3 Kidney diseases

10.1.4 Diabetes

10.1.5 Other

10.2 Pregnancy and Fertility

11. Urinalysis Market Segmentation, By End User Type

11.1 Diagnostic Laboratories

11.2 Home Care Settings

11.3 Research Laboratories

11.4 Hospitals and Clinics

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2 Canada

12.2.3 Mexico

12.3 Europe

12.3.1 Germany

12.3.2 UK

12.3.3 France

12.3.4 Italy

12.3.5 Spain

12.3.6 The Netherlands

12.3.7 Rest of Europe

12.4  Asia-Pacific

12.4.1 Japan

12.4.2 South Korea

12.4.3 China

12.4.4 India

12.4.5 Australia

12.4.6 Rest of Asia-Pacific

12.5 The Middle East & Africa

12.5.1 Israel

12.5.2 UAE

12.5.3 South Africa

12.5.4 Rest

12.6 Latin America

12.6.1 Brazil

12.6.2 Argentina

12.6.3 Rest of Latin America

13. Company Profiles

13.1 Roche Diagnostics

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 Siemens Healthcare

13.3 Sysmex Corporation

13.4 Elektronika KFT

13.5 Arkray Inc.

13.6 Beckman Coulter Inc.

13.7 Roche Diagnostics

13.8 Mindray Medical International Limited

13.9 URIT Medical Electronic Group Co. Ltd.

13.10 Acon Laboratories Inc.

13.11 Bio-Rad Laboratories Inc.

14. Competitive Landscape

14.1 Competitive Benchmark

14.2 Market Share Analysis

14.3 Recent Developments

15. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone